With the formation of a new strategic partnership, Dyno Therapeutics is responsible for the development of novel AAV capsids.
Dyno Therapeutics has recently announced the formation of a new strategic partnership with Swiss pharma giant Roche to ...
In this case report, Gad and colleagues performed corneal confocal microscopy to assess for evidence of nerve regeneration ...
Immunosuppressants used in adeno-associated virus (AAV) gene therapy for monogenic disorders present an adverse effect profile that is consistent with high-dose steroid use in other conditions ...
Detailed price information for Taysha Gene Therapies Inc (TSHA-Q) from The Globe and Mail including charting and trades.
Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on Taysha Gene Therapies (TSHA – Research Report) yesterday and set a ...
Taysha Gene Therapies (TSHA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...
Little research has explored family experiences after preimplantation genetic testing (PGT) for monogenic disorders (PGT-M) ...
London – 28 October 2024 - Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, presented preclinical data at the American Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback